Healthcare Providers and Services
Company Overview of Integrated Diagnostics Holdings plc
Integrated Diagnostics Holdings plc provides various medical diagnostics services to patients and other laboratories in Egypt, Jordan, and Sudan. The company offers pathology and molecular diagnostics, genetics testing, and basic radiology services. It provides diagnostics services in the areas of immunology, hematology/coagulation, clinical chemistry, parasitology, microbiology/infectious diseases, toxicology, cytology, surgical pathology, flow cytometry, molecular biology, cytogenetic, hepatitis, and influenza. As of December 31, 2014, the company operated 288 labs. Integrated Diagnostics Holdings plc was founded in 1979 and is headquartered in Saint Helier, the Channel Islands.
12 Castle Street
Saint Helier, JE2 3RT
Founded in 1979
Key Executives for Integrated Diagnostics Holdings plc
Group Chief Financial Officer
Total Annual Compensation: £511.2K
Managing Director of Ultralab
Total Annual Compensation: $117.6K
Managing Director of Biolab
Total Annual Compensation: 100.0K
Chief Information Officer
Total Annual Compensation: £594.0K
Investor Relations Director
Compensation as of Fiscal Year 2014.
Integrated Diagnostics Holdings plc Key Developments
Integrated Diagnostics Holdings plc Proposes Final Dividend for the Financial Year Ending December 31, 2015
Mar 29 16
Integrated Diagnostics Holdings plc proposed paying a final dividend of $0.06 per share (totaling $9 million in aggregate) to shareholders in respect of the financial year ending December 31, 2015. The company should be paid to shareholders of record as at April 8, 2016, with an ex-dividend date of April 7, 2016. The payment date for the dividend is May 13, 2016.
Integrated Diagnostics Holdings plc Reports Consolidated Earnings Results for the Full Year of 2015
Mar 29 16
Integrated Diagnostics Holdings plc reported consolidated earnings results for the full year of 2015. For the period, the company reported revenue of EGP 1,014,844,000 compared with EGP 860,231,000 for the same period last year. Operating profit was EGP 267,461,000 compared with EGP 250,485,000 for the same period last year. Profit before tax was EGP 274,493,000 compared with EGP 103,241,885,000 for the same period last year. Profit attributed to owners of the company was EGP 144,873,000 or EGP 0.97 basic and diluted earnings compared with EGP 132,769,000 or EGP 0.89 basic and diluted earnings for the same period last year. Net cash from operating activities was EGP 189,862,000 compared with net cash from operation EGP 301,587,000 for the same period last year. Acquisition of purchase of Property, plant and equipment was EGP 54,897,000 compared with EGP 76,089,000 for the same period last year. EBITDA of EGP 303.7 million, down 17% from 2014, largely as a result of costs associated with IDH's listing on the London Stock Exchange. Normalized EBITDA of EGP 434.8 million, up 16% from a normalized EBITDA of EGP 374.4 million in 2014.
Integrated Diagnostics Holdings plc Presents at The 12th Annual EFG Hermes One on One Conference, Mar-07-2016
Dec 28 15
Integrated Diagnostics Holdings plc Presents at The 12th Annual EFG Hermes One on One Conference, Mar-07-2016 . Venue: Atlantis, The Palm, Dubai, United Arab Emirates.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|